COVID-19 vaccines for children may be available by September: NIV director
India | August 19, 2021 12:11 ISTUnion Health Minister Mansukh Mandaviya had told BJP MPs that Covid vaccination for children is likely to start soon.
Union Health Minister Mansukh Mandaviya had told BJP MPs that Covid vaccination for children is likely to start soon.
The cumulative number of COVID-19 vaccine doses administered in the country has surpassed 55 crore.
As of Saturday morning, Delhi had 6,87,150 coronavirus vaccines in its balance stock, of which, 3,96,110 doses were of Covishield and 2,91,040 of Covaxin, according to the Covid vaccination bulletin issued by the government.
Cyrus Poonawalla on Friday strongly affirmed that mixing two different vaccines of COVID-19 is a very risky decision and it is must be discouraged.
According to an SBI report, 43 per cent of the eligible population in India stands vaccinated against Covid-19 with the first dose and 12 per cent with the second dose.
The Drugs Controller General of India (DCGI) has accepted a proposal for a research to analyse mixing a dose each of Covishield and Covaxin.
The Centre has approved a vaccine manufacturing facility for the production of Covaxin in Gujarat's Ankleshwar.
India launched vaccination for all people aged more than 45 from April 1. The government then decided to expand its vaccination drive by allowing everyone above 18 eligible to be vaccinated from May 1.
"The present rate of COVID-19 vaccine supply," will take another year for all to get vaccinated, says the Delhi health department.
ICMR said that mixing and matching of vaccines Covishield and Covaxin can yeild better results against Covid-19.
The meeting was held to discuss the Covishield supply and to ramp up the production in India. Minister Mandaviya assured the government's support in Covishield production.
The vaccine maker stated that as of date, all batches of Covaxin were manufactured and released from its manufacturing facilities at Genome Valley, Hyderabad, which are fully audited and approved by regulatory authorities.
Five states -- Madhya Pradesh, Gujarat, Rajasthan, Maharashtra and Uttar Pradesh -- have administered more than one crore vaccine doses each to beneficiaries in the 18-44 age group.
The approval received is from the National Institute of Pharmacy and Nutrition, Hungary certifying the GMP for the manufacture of Covaxin, a note posted on twitter said.
The monthly vaccine production capacity of Covishield is projected to be increased from 110 million doses per month to more than 120 million doses per month and the production capacity of Covaxin is projected to be increased from 25 million doses per month to around 58 million doses per month, government said.
The government on Tuesday informed the Parliament that no recommendation was made on mixing anti-coronavirus vaccines.
ICMR reveals that Covaxin is effective against the Delta Plus variant of COVID 19.
The Delhi government had on July 22 ordered that only the second dose of Covishield vaccine will be administered at government inoculation centres till July 31 due to limited supply.
An expert panel of India's central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a clinical trial of mixing of two COVID-19 vaccines -- Covaxin and Covishield -- official sources said.
59-year-old Manual Mathai has taken up the complaint with the district medical officer of Wayanad along with copies of the vaccine certificate he received.
Top News
Latest News
